Polyphor Ltd - Product Pipeline Review - 2016

Date: December 21, 2016
Pages: 39
Price:
US$ 1,500.00 US$ 1,275.00
Offer valid until March 3, 2017!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P4A9CC80F0CEN
Leaflet:

Download PDF Leaflet

Polyphor Ltd - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Polyphor Ltd - Product Pipeline Review - 2016’, provides an overview of the Polyphor Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Polyphor Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope
  • The report provides a snapshot of the pipeline therapeutic landscape of Polyphor Ltd
  • The report provides overview of Polyphor Ltd including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Polyphor Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Polyphor Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Polyphor Ltd’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Polyphor Ltd
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Polyphor Ltd’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Introduction
Global Markets Direct Report Coverage
Polyphor Ltd Snapshot
Polyphor Ltd Overview
Key Facts
Polyphor Ltd - Research and Development Overview
Key Therapeutic Areas
Polyphor Ltd - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Polyphor Ltd - Pipeline Products Glance
Polyphor Ltd - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Polyphor Ltd - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Polyphor Ltd - Drug Profiles
balixafortide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
POL-5551 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
POL-6014 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
POL-6926 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
POL-7001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
POL-7080 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
POL-7080 Follow-On - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Unspecified Indication - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptides for Unspecified Indication - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptides to Agonize FPR1/2 for Immunology and Infectious Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptides to Antagonize FPR1/2 for Immunology and Infectious Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Polyphor Ltd - Pipeline Analysis
Polyphor Ltd - Pipeline Products by Target
Polyphor Ltd - Pipeline Products by Route of Administration
Polyphor Ltd - Pipeline Products by Molecule Type
Polyphor Ltd - Pipeline Products by Mechanism of Action
Polyphor Ltd - Dormant Projects
Polyphor Ltd - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
POL-7080
Polyphor Ltd - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Polyphor Ltd, Key Facts
Polyphor Ltd - Pipeline by Indication, 2016
Polyphor Ltd - Pipeline by Stage of Development, 2016
Polyphor Ltd - Monotherapy Products in Pipeline, 2016
Polyphor Ltd - Partnered Products in Pipeline, 2016
Polyphor Ltd - Partnered Products/ Combination Treatment Modalities, 2016
Polyphor Ltd - Phase II, 2016
Polyphor Ltd - Phase I, 2016
Polyphor Ltd - Preclinical, 2016
Polyphor Ltd - Discovery, 2016
Polyphor Ltd - Pipeline by Target, 2016
Polyphor Ltd - Pipeline by Route of Administration, 2016
Polyphor Ltd - Pipeline by Molecule Type, 2016
Polyphor Ltd - Pipeline Products by Mechanism of Action, 2016
Polyphor Ltd - Dormant Developmental Projects,2016
Polyphor Ltd - Discontinued Pipeline Products, 2016

LIST OF FIGURES

Polyphor Ltd - Pipeline by Top 10 Indication, 2016
Polyphor Ltd - Pipeline by Stage of Development, 2016
Polyphor Ltd - Monotherapy Products in Pipeline, 2016
Polyphor Ltd - Pipeline by Target, 2016
Polyphor Ltd - Pipeline by Route of Administration, 2016
Polyphor Ltd - Pipeline by Molecule Type, 2016
Polyphor Ltd - Pipeline Products by Mechanism of Action, 2016
Skip to top


Allergic Conjunctivitis - Pipeline Review, H2 2016 US$ 1,700.00 Oct, 2016 · 71 pages

Ask Your Question

Polyphor Ltd - Product Pipeline Review - 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: